Modulation of atherogenesis by chemokines

Trends in Cardiovascular Medicine

Volumn 14, Issue 4, 2004, Pages 161-165

  Boisvert, William A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CX3C CHEMOKINE; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; CELL DAMAGE; CELL FUNCTION; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE THERAPY; GROWTH REGULATION; HUMAN; HYPERCHOLESTEROLEMIA; LEUKOCYTE MIGRATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASCULARIZATION;

EID: 2942564175     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2004.02.006     Document Type: Review

References (41)

1. Aiello R.J., Bourassa P.A., Lindsey S., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 19:1999;1518-1525
2. Apostolopoulos J., Davenport P., Tipping P.G. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol. 16:1996;1007-1012
3. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu Rev Immunol. 15:1997;675-705
4. Bazan J.F., Bacon K.B., Hardiman G., et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 385:1997;640-644
5. Boisvert W.A., Santiago R., Curtiss L.K., et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 101:1998;353-363
6. Boring L., Gosling J., Chensue S.W., et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 100:1997;2552-2561
7. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897
8. Combadiere C., Potteaux S., Gao J.L., et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation. 107:2003;1009-1016
9. Dawson T.C., Kuziel W.A., Osahar T.A., et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 143:1999;205-211
10. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 398:1999;718-723
11. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell. 104:2001;503-516
12. Goda S., Imai T., Yoshie O., et al. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J Immunol. 164:2000;4313-4320
13. Gosling J., Slaymaker S., Gu L., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 103:1999;773-778
14. Greaves D.R., Hakkinen T., Lucas A.D., et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 21:2001;923-929
15. Gu L., Okada Y., Clinton S.K., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 2:1998;275-281
16. Han K.H., Tangirala R.K., Green S.R., et al. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol. 18:1998;1983-1991
17. Han K.H., Chang M.K., Boullier A., et al. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J Clin Invest. 106:2000;793-802
18. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:2001;1876-1890
19. Hayes I.M., Jordan N.J., Towers S., et al. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol. 18:1998;397-403
20. Huo Y., Weber C., Forlow S.B., et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest. 108:2001;1307-1314
21. Ikeda U., Ikeda M., Seino Y., et al. Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis. 104:1993;61-68
22. Imai T., Hieshima K., Haskell C., et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 91:1997;521-530
23. Inoue S., Egashira K., Ni W., et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation. 106:2002;2700-2706
24. -/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest. 111:2003;333-340
25. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 338:1998;436-445
26. McDermott D.H., Halcox J.P., Schenke W.H., et al. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res. 89:2001;401-407
27. McDermott D.H., Fong A.M., Yang Q., et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest. 111:2003;1241-1250
28. Moatti D., Faure S., Fumeron F., et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood. 97:2001;1925-1928
29. Ni W., Egashira K., Kitamoto S., et al. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation. 103:2001;2096-2101
30. Ono S.J., Nakamura T., Miyazaki D., et al. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol. 111:2003;1185-1199
31. Reape T.J., Groot P.H. Chemokines and atherosclerosis. Atherosclerosis. 147:1999;213-225
32. Roque M., Kim W.J., Gazdoin M., et al. CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol. 22:2002;554-559
33. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126
34. Schall T. Fractalkine - a strange attractor in the chemokine landscape. Immunol Today. 18:1997;147
35. Schecter A.D., Rollins B.J., Zhang Y.J., et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem. 272:1997;28, 568-28, 573
36. Terkeltaub R., Boisvert W.A., Curtiss L.K. Chemokines and atherosclerosis. Curr Opin Lipidol. 9:1998;397-405
37. van Royen N., Hoefer I., Buschmann I., et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res. 57:2003;178-185
38. Viedt C., Vogel J., Athanasiou T., et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol. 22:2002;914-920
39. Wang N., Tabas I., Winchester R., et al. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 271:1996;8837-8842
40. Weber K.S., von Hundelshausen P., Clark-Lewis I., et al. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol. 29:1999;700-712
41. Wong B.W., Wong D., McManus B.M. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol. 11:2002;332-338